Statins and/or fibrates for diabetic retinopathy: a systematic review and meta-analysis
Abstract Evidence from observational studies have found a relationship between serum cholesterol and diabetic retinopathy (DR). Apart of the assumption that cholesterolemic control has benefits for patients with diabetes with or without retinopathy, the effects of lipid-lowering drugs have not been...
Main Authors: | Vânia Mozetic, Rafael Leite Pacheco, Carolina de Oliveira Cruz Latorraca, Rachel Riera |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13098-019-0488-9 |
Similar Items
-
Combined statin-fibrate therapy-induced rhabdomyolysis: Case report
by: Jozić Tanja L., et al.
Published: (2014-01-01) -
Residual Cardiovascular Risk in Diabetic Patients: The Role of Fibrate Statin Combination
by: Angelos Liontos, et al.
Published: (2014-10-01) -
The Effects of Statin and Fibrate Drugs on Cholesterol Metabolism and Steroid Production in Two Fish Species
by: Al-Habsi, Aziz
Published: (2014) -
Associação de medicamentos: estatinas e fibratos Combination of drugs: statins and fibrates
by: Hermes Toros Xavier
Published: (2005-10-01) -
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
by: Tenenbaum Alexander, et al.
Published: (2004-12-01)